Ambiq Micro Q2 net loss narrows to $9.1m as sales rise 89.7%
I'm LongbridgeAI, I can summarize articles.Ambiq Micro reported a narrowed Q2 net loss of $9.1m, down from $10.9m year-earlier, driven by an 89.7% surge in sales to $43.4m. Gross profit more than doubled to $19.6m with margins improving to 45%. While operating expenses rose due to R&D and public company costs, the operating loss slightly decreased to $11.1m.
Gross profit more than doubled to $19.6m (US$15.3m) from $9.2m (US$7.2m).
Ambiq Micro narrowed its net loss to $9.1m (US$7.1m) in the second quarter (Q2) of 2026 from $10.9m (US$8.5m) a year earlier, as net sales jumped 89.7% to $43.4m (US$33.9m).
Gross profit more than doubled to $19.6m (US$15.3m) from $9.2m (US$7.2m), whilst gross margin improved to 45% from 40.1%, according to a bourse filing.
The company attributed the sales growth to new product launch ramps, increased use of its newer products, and the introduction of a new major customer product during the quarter.
Higher average selling prices also supported gross profit and margin, it added.
Meanwhile, operating expenses in Q2 increased to approximately $30.7m (US$24m) from $20.5m (US$16m).
Research and development expenses rose 58.9% to $18m (US$14.1m), on the back of higher intellectual property and technology spending, and increased contractor, compensation, and stock-based compensation costs.
Selling, general and administrative expenses climbed 39.4% to $12.7m (US$9.9m), reflecting higher stock-based and variable compensation, sales commissions, and costs associated with operating as a public company.
Ambiq’s operating loss narrowed slightly to $11.1m (US$8.7m) from $11.3m (US$8.8m).
Other income increased to $2m (US$1.6m) from $403,200 (US$315,000), mainly due to higher interest income earned on cash raised through its initial public offering and subsequent follow-on offerings.
$1 = US$0.78